WGRX
Wellgistics Health, Inc.
$2.98
-0.09 (-2.93%)
At close · Jul 2
Going-concern doubt
— flagged May 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern within twelve months from the date these unaudited condensed consolidated financial statements are issued.”View the 10-Q filed May 19, 2026
Market Cap
$374.50M
Shares
125,671,251
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.98
Open$3.05
Day$2.89–3.08
52W$0.07–4.49
Avg vol 30d5.4M
Short int101K · 0.1% float · 1.4d
Short vol33%
Last earningsMay 19, 2026
DataFeb 2025–Jul 2026
Filing10-Q · May 19
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Buy
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+258% above
+
Price vs 50-day avg
+52% above
◦
RSI (14)
52 · neutral
−
MACD trend
negative
◦
52-week position
66% · mid-range
Sentiment · smart money
Neutral
◦
Trend (MA cross)
50d $2 › 200d $1 — 50d above 200d
−
Institutional flow
-32% holders QoQ · +5 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.08% of float · ▼ -77.2% MoM · 1.4 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
13 holders — mid 1-yr range
Fundamentals
Weak
+
Revenue growth
+29% Y/Y
−
Gross margin
-28%, contracting
−
EPS growth
−853% Y/Y
−
Balance sheet
net debt $34.3M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Oct 1, 2026
Est · unconfirmed
· in 13 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 19, 2026
Guidance & track record
Latest guidance
· from the 8-K filed May 19, 2026
Revenue
· Q2-2026
Initiated
$1.78M
prior qtr $1.56M
midpoint +13.8% QoQ
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+258% above
Bullish
Price vs 50-day avg
+52% above
Bullish
RSI (14)
52 · neutral
Neutral
MACD trend
negative
Bearish
52-week position
66% · mid-range
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $2 › 200d $1 — 50d above 200d
Institutional flow
Distributing
-32% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.08% of float · ▼ -77.2% MoM · 1.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
13 holders — mid 1-yr range
Price context
position in its 52-week range
52-wk low $0
Now $3 · 66%
52-wk high $4
vs 200-day avg +258%
vs 50-day avg +52%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Pharmaceutical Retailers — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
WGRX
this stock
Wellgistics Health, Inc.
|
$374.50M | +645.0% | +0.0% | — | 0.1% |
|
RTEZ
REST EZ Inc.
|
$1.93B | +0.0% | — | — | 0.0% |
|
HITI
High Tide Inc.
|
$200.64M | -13.2% | — | — | 0.6% |
|
BHIC
BioScience Health Innovations, Inc.
|
$48.13M | +5.4% | +208.3% | 140.5 | 0.0% |
|
SHFH
Scientist Home Future Health Ltd
|
$45.06M | — | — | — | — |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| WGRX | +4.2% | -32.1% | +639.5% | -3.9% | +645.0% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +2.8% | -30.9% | +631.4% | -3.6% | +635.8% |